AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
(L) First and co-corresponding author Charlie Wright, PhD, St. and (R) co-corresponding author Paul Geeleher, PhD, both of the St. Jude Department of Computational Biology. (MEMPHIS, Tenn. – December ...
In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at Stanford University and, until just a few months ago, chief computing ...
In 2023, North America dominated the the global AI in drug discovery market and is poised to maintain this leadership during ...
Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...
Predictive Oncology Inc. announced the successful development of predictive models for 21 unique compounds sourced from the University of Michigan's Natural Products Discovery Core, marking a ...
Artificial intelligence (AI) machine learning is transforming pharmaceutical drug discovery. Advances in deep learning, a subset of machine learning, is enabling researchers to identify patterns in ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback